Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ATM mutation + CDK12 mutation
i
Other names:
ATM, ATA, ATC, ATD, ATDC, TEL1, TELO1, ATM serine/threonine kinase
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
472
;
51755
Related biomarkers:
Expression
Mutation
CNA
Others
‹
ATM mutation (51)
CDK12 mutation (15)
ATM mutation + IGH mutation (2)
ATM S978fs*12 (2)
EGFR mutation + ATM mutation (2)
ASXL1 mutation + ATM mutation (1)
ATM D2721N (1)
ATM G2695D (1)
ATM PI2629fs* (1)
ATM S1905Ifs*25 + STK11 K262Sfs*25 (1)
ATM W2845 (1)
ATM biallelic inactivation (1)
ATM biallelic mutation (1)
ATM L804fs*4 (1)
BRCA1 mutation + ATM mutation (1)
BRCA2 mutation + ATM mutation (1)
CHEK2 mutation + ATM mutation + BRCA2 mutation (1)
EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)
KRAS G12C + ATM wild-type (1)
KRAS mutation + ATM mutation (1)
RET M918T + ATM L804fs*4 + ATM S978fs*12 (1)
TP53 mutation + ATM mutation (1)
BRCA2 mutation + CDK12 mutation (1)
ATM R337H (0)
ATM T2333fs* (0)
ATM mutation (51)
CDK12 mutation (15)
ATM mutation + IGH mutation (2)
ATM S978fs*12 (2)
EGFR mutation + ATM mutation (2)
ASXL1 mutation + ATM mutation (1)
ATM D2721N (1)
ATM G2695D (1)
ATM PI2629fs* (1)
ATM S1905Ifs*25 + STK11 K262Sfs*25 (1)
ATM W2845 (1)
ATM biallelic inactivation (1)
ATM biallelic mutation (1)
ATM L804fs*4 (1)
BRCA1 mutation + ATM mutation (1)
BRCA2 mutation + ATM mutation (1)
CHEK2 mutation + ATM mutation + BRCA2 mutation (1)
EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)
KRAS G12C + ATM wild-type (1)
KRAS mutation + ATM mutation (1)
RET M918T + ATM L804fs*4 + ATM S978fs*12 (1)
TP53 mutation + ATM mutation (1)
BRCA2 mutation + CDK12 mutation (1)
ATM R337H (0)
ATM T2333fs* (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ATM mutation + CDK12 mutation
Prostate Cancer
ATM mutation + CDK12 mutation
Prostate Cancer
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login